The Immunogenicity, Reactogenicity, and Safety of a Bivalent Mrna or Protein-Based COVID-19 Vaccine Given As a Fourth Dose in Healthy Adults in Australia: a Randomised Controlled Trial
crossref(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined